| Methods in Enzymology
| [0017]
|
| Towards safe, non-viral therapeutic gene expression in humans
| [0103]
|
| Knocking down barriers: advances in siRNA delivery
| [0103]
|
| Handbook of Cell-Penetrating Peptides
| [0103]
|
| Twenty years of cell-penetrating peptides : from molecular mechanisms to therapeutics
| [0103]
|
| Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy
| [0103]
|
| Cell-penetrating peptides: tools for intracellular delivery of therapeutics
| [0103]
|
| A new peptide vector for efficient delivery of oligonucleotides into mammalian cells
| [0103]
|
| A peptide carrier for the delivery of biologically active proteins into mammalian cells
| [0103]
|
| Prediction of peptide structure: how far are we?
| [0103]
|
| Disulfide bond as peptide-resin linkage in Boc-Bzl SPPS, for potential biochemical applications
| [0103]
|
| Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth
| [0103]
|
| A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells
| [0103]
|
| Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation
| [0103]
|
| A microRNA component of the p53 tumour suppressor network
| [0103]
|
| MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells
| [0103]
|
| Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain
| [0103]
|
| Stapled peptides for intracellular drug targets
| [0103]
|
| Synthesis of all-hydrocarbon stapled α-helical peptides by ring-closing olefin methathesis
| [0103]
|